Health Care & Life Sciences » Pharmaceuticals | Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC | Income Statement

Fiscal year is January-December. All values GBP Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
873
904
943
1,445
1,503
1,557
Cost of Goods Sold (COGS) incl. D&A
384
387
418
738
785
793
Gross Income
489
517
525
707
718
764
SG&A Expense
219
243
243
384
422
399
EBIT
249
241
243
251
251
319
Unusual Expense
40
10
20
76
790
65
Non Operating Income/Expense
4
13
20
24
11
4
Interest Expense
14
23
36
45
46
40
Pretax Income
193
223
209
156
573
220
Income Tax
52
49
42
39
78
6
Equity in Affiliates
2
4
1
-
-
-
Consolidated Net Income
138
171
166
117
651
214
Net Income
136
169
165
115
655
211
Net Income After Extraordinaries
136
169
165
115
655
211
Net Income Available to Common
136
169
165
115
655
211
EPS (Basic)
0.69
0.85
0.83
0.49
2.73
0.88
Basic Shares Outstanding
197
198
199
233
240
241
EPS (Diluted)
0.68
0.84
0.82
0.49
2.73
0.87
Diluted Shares Outstanding
198
200
201
234
240
242
EBITDA
290
281
289
334
356
400
Other Operating Expense
21
33
39
72
45
46
Non-Operating Interest Income
1
2
2
2
2
2
Minority Interest Expense
3
2
1
2
3
2

About Hikma Pharmaceuticals

View Profile
Address
1 New Burlington Place
London Greater London W1S 2HR
United Kingdom
Employees -
Website http://hikma.com
Updated 07/08/2019
Hikma Pharmaceuticals Plc engages in developing, manufacturing, and marketing branded and non-branded generic pharmaceutical products. It operates through the following segments: Branded, Injectables, Generics, and Others. The Branded segment offers selling of branded generics and in-licensed patented products.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.